Recombinant Human Thyrotropin Reduces Serum Vascular Endothelial Growth Factor Levels in Patients Monitored for Thyroid Carcinoma even in the Absence of Thyroid Tissue

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 10, 2003, Pages 4818-4822

  Sorvillo, Francesca ^a   Mazziotti, Gherardo ^a   Carbone, Antonella ^a   Piscopo, Marco ^a   Rotondi, Mario ^a   Cioffi, Michele ^a   Musto, Pasquale ^a   Biondi, Bernadette ^b   Iorio, Sergio ^a   Amato, Giovanni ^a   Carella, Carlo ^a,c  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT THYROTROPIN; THYROGLOBULIN; VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE SYNTHESIS; HUMAN; IN VIVO STUDY; MALE; METASTASIS; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID GLAND;

ADULT; CARCINOMA, PAPILLARY, FOLLICULAR; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 10744222344     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030789     Document Type: Article

References (33)

1. Folkman J, Watson K, Ingberg D, Hanahan D 1989 Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58-61
2. Folkman J 1990 What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6
3. Folkman J 1995 Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31
4. Ferrara N, Houch K, Jakeman L, Leung DW 1992 Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-31
5. Inoue K, Ozeki Y, Suganuma T, Sugiura Y, Tanaka S 1997 Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer 79:206-213
6. Soh EY, Duh QY, Sobhi SA, Young DM, Epstein HD, Wong MG, Garcia YK, Min YD, Grossman RF, Siperstein AE, Clark OH 1997 Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid. J Clin Endocrinol Metab 82:3741-3747
7. Imoto H, Osaki T, Taga S, Ohgami A, Ichiyoshi Y, Yasumoto K 1998 Vascular endothelial growth factor in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma. J Thorac Cardiovasc Surg 115:1007-1014
8. De Jong J, Van Diest P, Van Der Valk P, Baak J 1998 Expression of growth factors, growth inhibiting factors and their receptors in invasive breast cancer. II: Correlation with proliferation and angiogenesis. J Pathol 184:47-51
9. Crew J 1999 Vascular endothelial growth factor: an important angiogenic mediator in bladder cancer. Eur Urol 35:2-8
10. Poon RTP, Ng IO, Lau C, Zhu LX, Yu WC, Lo CM, Fan ST, Wong J 2001 Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg 233:227-235
11. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM 1995 Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55:3964-3968
12. Anan K, Morisaki T, Katano M, Ikubo A, Kitsuki H, Uchiyama A, Kuroki S, Tanaka M, Torisu M 1996 Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery 119:333-339
13. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogama M, Sawada T, Onoda N, Kato Y, Sawa M 1996 Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77:858-863
14. Fenton C, Patel A, Dinauer C, Robie DK, Tuttle RM, Francis GL 2000 The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults. Thyroid 10:349-357
15. Klein M, Vignaud JM, Hennequin V, Toussaint B, Bresler L, Plenat F, Leclere J, Duprez A, Weryha G 2001 Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma. J Clin Endocrinol Metab 86:656-658
16. Bunone G, Vigneri P, Mariani L, Buto S, Collini P, Pilotti S, Pierotti MA, Bongarzone I 1999 Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol 155:1967-1976
17. Lin SY, Wang YY, Sheu WH 2003 Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer. Clin Endocrinol (Oxf) 58:513-518
18. Ramsden JD 2000 Angiogenesis in the thyroid gland. J Endocrinol 166:475-480
19. Viglietto G, Maglione D, Rambaldi M, Cerutti J, Romano A, Trapasso F, Fedele M, Ippolito P, Chiappetta G, Botti G, Fusco A, Persico MG 1995 Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PIGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene 11:1569-1579
20. Iitaka M, Miura S, Yamanaka K, Kawasaki S, Kitahama S, Kawakami Y, Kakinuma S, Oosuga I, Wada S, Katayama S 1998 Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab 83:3908-3912
21. Klein M, Picard E, Vignaud JM, Marie B, Bresler L, Toussaint B, Weryha G, Duprez A, Leclere J 1999 Vascular endothelial growth factor gene and protein: strong expression in thyroiditis and thyroid carcinoma. J Endocrinol 161:41-49
22. Tuttle RM, Fleisher M, Francis GL, Robbins RJ 2002 Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation. J Clin Endocrinol Metab 87:1737-1742
23. Sato K, Yamazaki K, Shizume K, Kanaji Y, Obara T, Ohsumi K, Demura H, Yamaguchi S, Shibuya M 1995 Stimulation by thyroid-stimulating hormone and Graves' immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo. J Clin Invest 96:1295-1302
24. Miyagi E, Katoh R, Li X, Lu S, Suzuki K, Maeda S, Shibuya M, Kawaoi A 2001 Thyroid stimulating hormone downregulates vascular endothelial growth factor expression in FRTL-5 cells. Thyroid 11:539-543
25. Ladenson PW 1999 Recombinant human thyrotropin symposium. Strategies for thyrotropin use to monitor patients with treated thyroid carcinoma. Thyroid 9:429-433
26. Robbins R, Tuttle R, Sharaf R, Larson S, Robbins H, Ghossein R, Smith A, Drucher W 2001 Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma. J Clin Endocrinol Metab 86:619-625
27. Mazzaferri EL, Kloos RT 2000 Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions. Thyroid 10:767-778
28. Suzuki K, Mori A, Lavaroni S, Ullianich L, Mijagy E, Sato J, Nakazato M, Pietrarelli M, Shafran N, Grassadonia A, Kim WB, Consiglio E, Formisano S, Kohn LD 1999 Thyroglobulin regulates follicular function and heterogeneity by suppressing thyroid-specific gene expression. Biochimie (Paris) 81: 1-12
29. Dutton CM, Joba W, Spitzweg C, Heufelder AE, Bahn RS 1997 Thyrotropin receptor expression in adrenal, kidney and thymus. Thyroid 7:879-884
30. Sorisky A, Bell A, Gagnon A 2000 TSH receptor in adipose cells. Horm Metab Res 32:468-474
31. Koutras DA 1997 Disturbances of menstruation in thyroid disease. Ann N Y Acad Sci 816:280-284
32. Agrawal R, Jacobs H, Payne N, Conway G 2002 Concentration of vascular endothelial growth factor released cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. Fertil Steril 78:1164-1169
33. Mathur R, Hayman G, Bansal A, Jenkins J 2002 Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome highly responsive women undergoing assisted conception. Fertil Steril 78:1154-1158